RE: Still not much interest it appears.18 Nov 2021 13:26
Stampee,
"If all the dot's come into line how much could Scancell realistically be worth ?"
Two key phrases in your question - 1) "IF" and 2) "realistically"
It is easy to be drawn to mouth-watering figures like $120B for Covid vaccines. If you Google "Covid Vaccine Market" you will find estimates between $10B and $150B. Then you have to consider market share. Of whatever the market is worth, no one drug will get all that revenue. The Covid market is highly competitive with big players like Astra-Zeneca, Pfizer, Johnson and Johnson, Moderna all taking a hefty slice for themselves. Realistically, if Scancell manage 10% they will be doing well.
Then, as Scancell won't be able to bring this to market themselves, they will receive a royalty of perhaps 15%.
So, realistically, market $10B, share 10%, 15% royalty = £54M pounds profit per year. Assuming a PE of 10, that's 55p per share (fully diluted - 985M shares).
When you consider that Covid is only one one of the bow strings and the above figures are ultra conservative you can see how undervalued we are.